Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.91% is 13% below its 5-year average of 9.07%, near the low end of its 5-year range (4.09%–24.87%).
15.47% above its 12-month average of 6.85%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.71%.
RETURN ON ASSETS (ROA)
7.91%
RETURN ON ASSETS (ROA) AVG TTM
6.85%
RETURN ON ASSETS (ROA) AVG 3Y
11.28%
RETURN ON ASSETS (ROA) AVG 5Y
9.07%
RETURN ON ASSETS (ROA) AVG 10Y
7.74%
RETURN ON ASSETS (ROA) AVG 15Y
7.17%
RETURN ON ASSETS (ROA) AVG 20Y
10.10%
CURRENT VS TTM AVG
+15.47%
CURRENT VS 3Y AVG
-29.88%
CURRENT VS 5Y AVG
-12.82%
CURRENT VS 10Y AVG
+2.24%
CURRENT VS 15Y AVG
+10.39%
CURRENT VS 20Y AVG
-21.68%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+53.89%
vs the sector median at left
Market Cap
$101.46B
Return on Assets (ROA)
5.20%
TTM Avg
5.08%
3Y Avg
5.08%
5Y Avg
2.52%
Market Cap
$94.31B
Return on Assets (ROA)
11.30%
TTM Avg
10.43%
3Y Avg
10.23%
5Y Avg
10.42%
Market Cap
$104.41B
Return on Assets (ROA)
7.78%
TTM Avg
6.88%
3Y Avg
7.02%
5Y Avg
6.41%
Market Cap
$85.90B
Return on Assets (ROA)
3.93%
TTM Avg
4.89%
3Y Avg
5.25%
5Y Avg
5.41%
Market Cap
$113.46B
Return on Assets (ROA)
5.61%
TTM Avg
5.13%
3Y Avg
4.62%
5Y Avg
4.65%
Market Cap
$113.72B
Return on Assets (ROA)
1.93%
TTM Avg
1.25%
3Y Avg
1.93%
5Y Avg
2.38%
Market Cap
$81.19B
Return on Assets (ROA)
10.37%
TTM Avg
11.40%
3Y Avg
12.40%
5Y Avg
16.97%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GSK plc (GSK) | $98.65B | 7.91% | 6.85% | 11.28% | 9.07% |
| Sanofi (SNY)vs › | $98.71B | 3.12% | 5.18% | 5.31% | 6.19% |
| McKesson Corporation (MCK)vs › | $101.46B | 5.20% | 5.08% | 5.08% | 2.52% |
| HCA Healthcare, Inc. (HCA)vs › | $94.31B | 11.30% | 10.43% | 10.23% | 10.42% |
| Stryker Corporation (SYK)vs › | $104.41B | 7.78% | 6.88% | 7.02% | 6.41% |
| Elevance Health Inc. (ELV)vs › | $85.90B | 3.93% | 4.89% | 5.25% | 5.41% |
| Medtronic plc (MDT)vs › | $113.46B | 5.61% | 5.13% | 4.62% | 4.65% |
| CVS Health Corp. (CVS)vs › | $113.72B | 1.93% | 1.25% | 1.93% | 2.38% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $81.19B | 10.37% | 11.40% | 12.40% | 16.97% |
| Moderna, Inc. (MRNA)vs › | $78.91B | -28.75% | -24.02% | -10.32% | -0.33% |
ROA
7.9%
ROE
27.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 9.37% |
| 2024-12-31 | 4.33% |
| 2023-12-31 | 6.55% |
| 2022-12-31 | 24.87% |
| 2021-12-31 | 4.09% |
| 2020-12-31 | 5.23% |
| 2019-12-31 | 4.40% |
| 2018-12-31 | 6.24% |
| 2017-12-31 | 2.72% |
| 2016-12-31 | 1.54% |
| 2015-12-31 | 15.76% |
| 2014-12-31 | 6.78% |
| 2013-12-31 | 12.92% |
| 2012-12-31 | 10.85% |
| 2011-12-31 | 12.81% |
| 2010-12-31 | 3.89% |
| 2009-12-31 | 12.90% |
| 2008-12-31 | 11.68% |
| 2007-12-31 | 16.84% |
| 2006-12-31 | 21.08% |
| 2005-12-31 | 17.24% |
| 2004-12-31 | 17.02% |
| 2003-12-31 | 18.70% |
| 2002-12-31 | 17.62% |
| 2001-12-31 | 14.11% |
| 2000-12-31 | 19.28% |
| 1999-12-31 | 17.37% |
| 1998-12-31 | 19.64% |
| 1997-12-31 | 21.93% |
| 1996-12-31 | 24.02% |
